Otomagnetics

Otomagnetics is pioneering a novel, non-invasive drug delivery platform that uses magnetic forces to transport therapeutic agents across biological barriers. Its initial targets are the inner and middle ear, where current delivery methods are highly invasive or ineffective, addressing significant unmet needs in otology. The technology also holds promise for ocular and dermatological applications, potentially revolutionizing local drug administration. Founded in 2015, the company is in the pre-clinical development stage, building a platform with broad therapeutic potential.

Proprietary magnetic drug delivery platform using magnetic nanoparticles and an external magnetic device to non-invasively push therapeutic payloads across biological barriers to targeted anatomical sites (inner/middle ear, eye, skin).

Competition includes companies developing sustained-release implants or injections for the ear (e.g., past efforts by Otonomy) and eye (e.g., Genentech/Novartis). However, Otomagnetics' fully non-invasive, externally guided approach is potentially differentiating. It may also compete with other physical delivery methods like sonophoresis or iontophoresis.